Bridgeway Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Hold	17,500	–	–	0.01%	975
2025 Q4	$168K	Hold	17,500	–	–	﹤0.01%	1051
2025 Q3	$165K	Hold	17,500	–	–	﹤0.01%	1047
2025 Q2	$185K	Buy	+17,500	New	+$221K	﹤0.01%	976
2015 Q1	–	Sell	-18,339	Closed	-$747K	–	1476
2014 Q4	$747K	Hold	18,339	–	–	0.02%	885
2014 Q3	$672K	Sell	18,339 -200	-1%	-$8.64K	0.02%	941
2014 Q2	$859K	Sell	18,539 -16,100	-46%	-$716K	0.02%	836
2014 Q1	$1.42M	Sell	34,639 -62,050	-64%	-$2.31M	0.04%	619
2013 Q4	$3.69M	Buy	96,689 +50	+0.1%	+$1.54K	0.11%	204
2013 Q3	$2.31M	Buy	96,639 +200	+0.2%	+$4.49K	0.08%	362
2013 Q2	$1.64M	Buy	+96,439	New	+$1.39M	0.07%	426